Prescribing overview
Simplicef tablets contain cefpodoxime proxetil; doses express the active cefpodoxime moiety.
Key prescribing checks
- Screen for hypersensitivity to cefpodoxime and other beta-lactam antibiotics. A history of serious antibiotic allergy requires review.
- Use the patient’s infection assessment and, when appropriate, culture and susceptibility results to guide selection. This is not a treatment for nonbacterial skin disease.
- Gastrointestinal adverse effects and hypersensitivity reactions require follow-up. Failure to improve should trigger reassessment rather than automatic extension or substitution.
- The veterinary brand’s dog label does not establish approval in cats, rabbits or other species.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Dogs
US veterinary approved labelSusceptible bacterial skin infections, including wounds and abscesses
Organisms include S. intermedius, S. aureus, S. canis, E. coli, P. multocida and P. mirabilis.
Use / indication source ↗Pharmacology & pharmacokinetics
Mechanism and clinical role
The absorbed prodrug is de-esterified to cefpodoxime, a bacterial cell-wall synthesis inhibitor.
Absorption, distribution, metabolism and elimination
Fasting Beagles: oral bioavailability approximately 63%; predominantly urinary elimination with oral half-life approximately 5–6 hours.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
Simplicef
US canine oral cefpodoxime-proxetil label.
Contraindications · when not to use
- Known cefpodoxime or beta-lactam antibiotic allergy.
Precautions & monitoring
- Breeding, pregnancy and lactation safety has not been demonstrated; direct Coombs testing may become positive. Sensitized handlers should avoid contact.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
Vomiting, diarrhea, reduced appetite and beta-lactam hypersensitivity may occur.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
| Species & indication | Labeled regimen | Eligibility & source |
|---|---|---|
| DogsLabeled susceptible skin infectionsSimplicef 100 or 200 mg tablets | 5–10 mg/kg (2.3–4.5 mg/lb) active cefpodoxime Oral · Once daily 5–7 days or 2–3 days beyond sign resolution; maximum 28 days | With or without food. Acute infection nonresponse by 3–4 days requires reassessment, not continued empiric treatment. Verify full dosing label ↗ |
No feline approval established; breeding/pregnancy/lactation safety unproven.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This is a selected interaction reference, not an automated or comprehensive combination checker. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
A product-specific interaction summary has not been established here. An empty list must not be interpreted as “no interactions.” Review the full source and a species-appropriate clinical reference.
Monitoring
Obtain culture/susceptibility before therapy and reassess results and clinical response.
Client counseling
Report allergy or digestive illness; avoid direct contact if beta-lactam sensitized.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Retain labeled container and follow package storage instructions.
Brands, formulations & ingredient identity
Active ingredients
Cefpodoxime proxetil
Other searchable names: cefpodoxime
Cefpodoxime is the active drug; cefpodoxime proxetil names the oral prodrug in this formulation. Both are useful search terms.
Simplicef tablets are not synonymous with every product containing a cephalosporin. Confirm exact ingredient and formulation before dispensing.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
Simplicef
- Formulation
- Oral tablet
- Label / product scope
- Dogs
Veterinary cefpodoxime proxetil product.
Product label / source ↗References & review status
Clinical reference updated October 16, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.
Search another medication or supplement →